Document Detail


Intravenous immunoglobulin, blood viscosity and myocardial infarction.
MedLine Citation:
PMID:  9284845     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Polyvalent intravenous immunoglobulin (IVIg) is considered to be standard therapy for a variety of autoimmune and idiopathic disorders. Several reports have emphasized the temporal association between administration of IVIg and thrombotic events. Recent experience with a patient who suffered a large myocardial infarction shortly after receiving IVIg led the authors to review the clinical and basic literature on administration of IVIg as a possible precipitant for myocardial infarction. Although the existence of an association between IVIg administration and myocardial ischemia has not been demonstrated in clinical trials, a body of clinical experience has begun to accumulate that is suggestive of an association between IVIg administration and cardiac and cerebral ischemia in older individuals or individuals with a known history of ischemic disease. Basic research demonstrating that IVIg administration may increase blood viscosity suggests that such an association is plausible.
Authors:
D N Fisman; M Smilovitch
Related Documents :
15566075 - Qualitative and quantitative description of myocardial ischemia by means of magnetocard...
23484435 - Prognostic value of qualitative and quantitative vasodilator stress myocardial perfusio...
9327705 - Frequency, duration, magnitude, and consequences of myocardial ischemia during intracor...
17652335 - Nandrolone potentiates arrhythmogenic effects of cardiac ischemia in the rat.
19949335 - Therapeutic potential of adipose-derived stem cells in vascular growth and tissue repair.
11025895 - T wave alternans as a risk predictor in patients with cardiomyopathy and mild-to-modera...
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  The Canadian journal of cardiology     Volume:  13     ISSN:  0828-282X     ISO Abbreviation:  Can J Cardiol     Publication Date:  1997 Aug 
Date Detail:
Created Date:  1997-09-12     Completed Date:  1997-09-12     Revised Date:  2008-04-09    
Medline Journal Info:
Nlm Unique ID:  8510280     Medline TA:  Can J Cardiol     Country:  CANADA    
Other Details:
Languages:  eng     Pagination:  775-7     Citation Subset:  IM    
Affiliation:
Department of Medicine, Royal Victoria Hospital, Montreal, Quebec. dfisman@bidmc.harvard.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Angina Pectoris / drug therapy
Blood Viscosity / drug effects*
Chronic Disease
Demyelinating Diseases / drug therapy*
Fatal Outcome
Humans
Immunoglobulins / administration & dosage,  adverse effects*
Injections, Intravenous
Male
Myocardial Infarction / chemically induced*
Polyneuropathies / drug therapy
Chemical
Reg. No./Substance:
0/Immunoglobulins

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Papillary fibroelastoma of the tricuspid valve.
Next Document:  Aging effects on the organic base transporter and stereoselective renal clearance.